[1]
Rusconi, C. et al. 2020. Treatment of very high-risk classical Hodgkin Lymphoma: cases’ selection from real life and critical review of the literature . Acta Biomedica Atenei Parmensis. 91, S-5 (May 2020), 13–22. DOI:https://doi.org/10.23750/abm.v91iS-5.9911.